SXTC
China SXT Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.23
+1.36%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
3.1x
Market Cap
$1.19M
MomentumView details →
1D Return
+1.36%
YTD Return
−99.99%
RSI (14)
23.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
3.1x
Market Cap
$1.19M
RSI (14)
23.3
MomentumView details →
1D Return
+1.36%
YTD Return
−99.99%
SummaryUpdated Mar 1, 2026
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) is a Chinese pharmaceutical company founded in 2005 and headquartered in Taizhou, China. The company went public on the NASDAQ in January 2019. SXT specializes in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP), operating primarily within China's healthcare market. The company has experienced significant financial volatility in recent years, with fluctuating revenues and alternating periods of profitability and losses.
Similar companies
Latest newsMore news →